Evidence map›Paper›PMID 40404994›Full record

ArticleNature methods2025

Cell simulation as cell segmentation.

Daniel C Jones, Anna E Elz, Azadeh Hadadianpour, Heeju Ryu, David R Glass, Evan W Newell

Abstract read
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Trial
  2. Spatial Transcriptomics Analysis of Ewing Sarcoma.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Daniel C JonesVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. djones3@fredhutch.org.ORCID http://orcid.org/0000-0001-7055-3119
Anna E ElzImmunotherapy Integrated Research Center, Fred Hutchinson Cancer, Seattle, WA, USA.
Azadeh HadadianpourImmunotherapy Integrated Research Center, Fred Hutchinson Cancer, Seattle, WA, USA.
Heeju RyuVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
David R GlassVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-9924-167X
Evan W NewellVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. enewell@fredhutch.org.ORCID http://orcid.org/0000-0002-2889-243X

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STEPHANIE J LEE · 1985 to 2026
$128.4M
Systems Biology CoreU19AI128914 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KENNETH D STUART · 2017 to 2026
$29.5M
Understand & overcome resistance to PD-1P01CA225517 · NCI · UNIVERSITY OF WASHINGTON · PI PAUL NGHIEM · 2019 to 2026
$22.7M
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinomaR01CA264646 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWELL, EVAN · 2021 to 2025
$3.0M
NCI NIH HHS P01 CA018029NCI NIH HHS P01 CA225517NCI NIH HHS R01 CA264646NIAID NIH HHS U19 AI128914U.S. Department of Health & Human Services | National Institutes of Health (NIH) U19AI128914
6 · The paper itself

Abstract

Single-cell spatial transcriptomics promises a highly detailed view of a cell's transcriptional state and microenvironment, yet inaccurate cell segmentation can render these data murky by misattributing large numbers of transcripts to nearby cells or conjuring nonexistent cells. We adopt methods from ab initio cell simulation, in a method called Proseg (probabilistic segmentation), to rapidly infer morphologically plausible cell boundaries. Benchmarking applied to datasets generated by three commercial platforms shows superior performance and computational efficiency of Proseg when compared to existing methods. We show that improved accuracy in cell segmentation aids greatly in detection of difficult-to-segment tumor-infiltrating immune cells such as neutrophils and T cells. Last, through improvements in our ability to delineate subsets of tumor-infiltrating T cells, we show that CXCL13-expressing CD8

Indexed as

Single-Cell AnalysisAlgorithmsCarcinoma, Renal CellCD8-Positive T-LymphocytesChemokine CXCL13Computational BiologyComputer SimulationGene Expression ProfilingHumansKidney NeoplasmsLymphocytes, Tumor-InfiltratingNeutrophilsTranscriptomeTumor MicroenvironmentChemokine CXCL13

Identifiers

PMID40404994
PMCPMC12285883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.